Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanliang Cheng

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Asian Journal of Surgery|October 14, 2023
The unintended consequences of photodynamic therapy in cholangiocarcinoma: A case of septic shockChuanliang Cheng, Wen Cheng, Qing Tian
ISA Transactions|February 4, 2024
An effective multi-model based nonlinear control for USC power plantChuanliang Cheng, Chen Peng, Xiangpeng Xie, et al.
ISA Transactions|April 5, 2023
An optimized nonlinear generalized predictive control for steam temperature in an ultra supercritical unitChuanliang Cheng, Chen Peng, Tengfei Zhang, et al.
American Journal of Health Behavior|May 25, 2023
Effects of Group Prenatal Health Care Combined with Happiness Training on Delivery Mode and Maternal Role Adaptation in Elderly Primiparous Women: A Study for Improvements in Patients Health BehaviorShuangqin Zhang, Ziqiang Qian, Yingchun Zhao, et al.
Frontiers in Bioengineering and Biotechnology|January 8, 2024
Advancements and application prospects of three-dimensional models for primary liver cancer: a comprehensive reviewLiuyang Zhu, Chuanliang Cheng, Sen Liu, et al.
Frontiers in Immunology|August 15, 2022
Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencingYi Bai, Dapeng Chen, Chuanliang Cheng, et al.
Stem Cell Research & Therapy|August 7, 2024
Liver organoids: updates on generation strategies and biomedical applicationsSen Liu, Chuanliang Cheng, Liuyang Zhu, et al.
International Immunopharmacology|October 19, 2025
Cholangiocarcinoma-derived SPP1 drives tumor progression by inducing macrophage chemotaxis and M2 polarizationTianze Wang, Pinsheng Han, Chuanliang Cheng, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort studyJianfa Yu, Yi Bai, Zilin Cui, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Asian Journal of Surgery|October 14, 2023
The unintended consequences of photodynamic therapy in cholangiocarcinoma: A case of septic shockChuanliang Cheng, Wen Cheng, Qing Tian
ISA Transactions|February 4, 2024
An effective multi-model based nonlinear control for USC power plantChuanliang Cheng, Chen Peng, Xiangpeng Xie, et al.
ISA Transactions|April 5, 2023
An optimized nonlinear generalized predictive control for steam temperature in an ultra supercritical unitChuanliang Cheng, Chen Peng, Tengfei Zhang, et al.
American Journal of Health Behavior|May 25, 2023
Effects of Group Prenatal Health Care Combined with Happiness Training on Delivery Mode and Maternal Role Adaptation in Elderly Primiparous Women: A Study for Improvements in Patients Health BehaviorShuangqin Zhang, Ziqiang Qian, Yingchun Zhao, et al.
Frontiers in Bioengineering and Biotechnology|January 8, 2024
Advancements and application prospects of three-dimensional models for primary liver cancer: a comprehensive reviewLiuyang Zhu, Chuanliang Cheng, Sen Liu, et al.
Frontiers in Immunology|August 15, 2022
Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencingYi Bai, Dapeng Chen, Chuanliang Cheng, et al.
Stem Cell Research & Therapy|August 7, 2024
Liver organoids: updates on generation strategies and biomedical applicationsSen Liu, Chuanliang Cheng, Liuyang Zhu, et al.
International Immunopharmacology|October 19, 2025
Cholangiocarcinoma-derived SPP1 drives tumor progression by inducing macrophage chemotaxis and M2 polarizationTianze Wang, Pinsheng Han, Chuanliang Cheng, et al.
Journal of Gastrointestinal Oncology|July 11, 2024
Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort studyJianfa Yu, Yi Bai, Zilin Cui, et al.
Pageof 1